Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway

Yu Zhang(Guangdong Laboratory Animals Monitoring Institute), Qin Wang(Southwest Medical University)
Molecular Medicine Reports
January 17, 2019
Cited by 20


Related Papers